Picture of Checkpoint Therapeutics logo

CKPT — Checkpoint Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy

Dec 18 (Reuters) - Checkpoint Therapeutics  CKPT.O  said
on Monday the U.S. Food and Drug Administration declined to
approve its experimental therapy to treat a type of advanced
skin cancer, citing issues related to a third-party contract
manufacturer.   

 (Reporting by Mariam Sunny in Bengaluru)
 ((Mariam.ESunny@thomsonreuters.com;))

Recent news on Checkpoint Therapeutics

See all news